Citations

Mayo Clinic

Showing 10 of 108279 citations.

Social network intervention for cardiovascular risk reduction among Hispanic and Somali adults: a cluster randomized trial
Molina, Luz, Goodson, Miriam, Capetillo, Graciela Porraz, Osman, Ahmed, Ahmed, Yahye, Nur, Omar, Iteghete, Sheila, Dirie, Hana, Clark, Matthew M. , Njeru, Jane W. , Pardo, Laura Suarez, Zeratsky, Katherine, Rieck, Thomas, Herrin, Jeph, Wieland, Mark L. , Molina, Luz, Goodson, Miriam, Ahmed, Yahye, Lohr, Abby M. , Patten, Christi A. , Zeratsky, Katherine, Rieck, Thomas , Herrin, Jeph , Valente, Thomas William , Sia, Irene G. , Wieland, Mark L , Porraz Capetillo, Graciela, Patten, Christi , Suarez Pardo, Laura, Herrin, Jeph

Annals of Behavioral Medicine | April 13, 2026 | Volume: 60 | Issue: 1 | Pages: No page available

10.1093/abm/kaag020 | PMID 42847369 Get It

Abstract Background Immigrants to the United States often face challenges from limited healthcare access and less healthy environments which contribute to rising obesity and cardiovascular risk. Purpose To assess the feasibility and effectiveness of a community-based social network intervention for cardiovascular risk reduction among Hispanic and Somali adults. Methods A social network-informed, community-based participatory research-derived health promotion intervention was delivered by Hispanic and Somali lay health promoters (HPs) to members of their social networks over 1 year (12 biweekly sessions in months 0-6; 12 biweekly check-ins in months 7-12). Using a closed-cohort stepped wedge cluster randomized design, social networks were randomly assigned to receive the intervention immediately or after a delay of 1 year. Measurements at baseline, 6 months, and 12 months were derived from 6 of the American Heart Association’s “Life’s Simple 7”: BMI, blood pressure, fasting glucose, cholesterol, physical activity and dietary quality (range 0-12, with higher values indicating lower cardiovascular risk). Waist circumference and proportion of participants who achieved >5% body weight loss were also assessed. Results Four hundred seventy-five participants were enrolled among 51 HPs (29 Hispanic; 22 Somali). There was a statistically significant improvement in cardiovascular risk in the intervention group (n = 246) compared with controls (n = 229) at 6 months (0.4 [1.8] vs. −0.1 [1.7]; P = .03) that was not sustained at 12 months (0.5 [1.9] vs. 0.3 [1.8]; P = .38). There was a statistically significant higher proportion of participants who lost >5% of body weight in the intervention group compared with controls at 12 months (37% [15] vs. 18% [7.9]; P = .02). Reductions in weight and waist circumference in the intervention group compared with controls did not achieve statistical significance. Conclusion A social network intervention, delivered by lay HPs was feasible and resulted in a modest improvement of cardiovascular risk and clinically significant weight loss. Clinical Trial Identification Number NCT05136339.
Inflammatory adenoma‐like hepatocellular neoplasm in cirrhotic livers
Shui, Yuan , Setia, Namrata , Graham, Rondell P. , Gill, Ryan M. , Li, Xinmin , French, Samuel W. , Naini, Bita V. , Hart, John , Wang, Hanlin L. , Graham, Rondell P , Hart, John A L

Histopathology | April 13, 2026 | Volume: 88 | Issue: 7 | Pages: 1466-1469

10.1111/his.70154 | PMID 41969142 Get It

Pasteurella Bacteremia: Clinical Presentation, Outcomes, and Mortality in a Retrospective Cohort
Walsh, Ellen , Higgins, Eibhlin , Dumais, Mitchell , Saleh, Omar Abu , Higgins, Eibhlin M , Dumais, Mitchell G , Walsh, Ellen , Fida, Madiha , Misra, Anisha

Zoonotic Diseases | April 13, 2026 | Volume: 6 | Issue: 2 | Pages: 13

10.3390/zoonoticdis6020013 Get It

Pasteurella species are facultatively anaerobic Gram-negative coccobacilli residing in the upper respiratory tract of mammals, fowl and domestic animals including cats and dogs. Localized infections with Pasteurella species are common but invasive infections are rare. There is a paucity of data available on risk factors, clinical presentations and outcomes with Pasteurella bloodstream infection. We conducted a retrospective review of patients with Pasteurella bacteremia presenting to our institution. There were 63 presentations (61 patients) with Pasteurella bacteremia. Immunosuppression, malignancy and alcohol misuse were common. Rates of admission to intensive care (n = 18, 29.5%) and death prior to hospital discharge (n = 7, 11.5%) were high.
CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case–control study
Arenas-Pinto, Alejandro, Nordwall, Jacqueline , Carey, Dianne , Fletcher, Courtney V., Thompson, Greg, Reilly, C. S., Safo, Sandra E. , Grund, Birgit , Arenas‐Pinto, Alejandro , Fletcher, Courtney Vail , Badley, Andrew D. , Lundgren, Jens

Frontiers in Pharmacology | April 13, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fphar.2026.1734919 | PMID 42051257 Get It

Background We analysed the association between host genetic risk scores (GRSs) predicting efavirenz (EFV) plasma levels and exposure and suicidal behaviours in participants in one of several global antiretroviral therapy (ART) clinical trials linked to the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). Methods We conducted a matched case–control study (two controls per case) on suicide or grade-4 suicidal ideation/attempts or depression. Cases and controls were matched by EFV initiation strategy, study, and follow-up time. CYP2B6-based GRS classified participants as extensive, intermediate, or slow metabolisers. EFV and its metabolites (8-hydroxy-EFV and 7-hydroxy-EFV) were measured in plasma. Conditional logistic regression was used to analyse the associations between GRS categories, EFV levels, and suicidal behaviour. Results Among 74 cases and 146 controls, 128 (58.2%) started EFV-containing first-line treatment. Of the treatment-experienced participants, 35% were on EFV at entry. Pre-existing psychiatric conditions and recreational drug-use were more common in cases (16.2%, 25.7%) than in controls (0.7%, 9.6%). On comparing cases to controls, more cases were extensive metabolisers (52% vs. 45%), but there were fewer slow metabolisers (8% vs. 13%). The unadjusted odds ratio (OR) for suicidal behaviour per one more minor allele was 0.76 (95% CI: 0.49–1.18). The OR for being a case vs. a control was 0.57 (95% CI: 0.38–0.86) per doubling of the EFV plasma level. Conclusion CYP2B6-based GRS for cytochrome P450 enzymatic activity appeared not to be associated with suicidal behaviour in individuals living with HIV treated with EFV-containing ART combinations. CYP2B6-based GRS effectively predicted EFV exposure, but suicidal behaviour appeared more likely in extensive (normal) metabolisers.
Chronic Thromboembolic Pulmonary Disease Phenotypes Using Upright Invasive Cardiopulmonary Exercise Testing
Kirupaharan, Pradhab , Wang, Xiaofeng, Wang, Yifan, Goyanes, Alice , Izakovich, Tereza, Tong, Michael Z., Elgharably, H., Haddadin, Ihab, Tonelli, Adriano R., Azar, Jehad , Wang, Y. , Wang, Xiaofeng, Tong, Michael Zhen‐Yu, Elgharably, Haytham J., Tonelli, Adriano R. , Heresi, Gustavo A.

Pulmonary Circulation | April 13, 2026 | Volume: 16 | Issue: 2 | Pages: No page available

10.1002/pul2.70298 | PMID 41982427 Get It

ABSTRACT Patients with chronic thromboembolic pulmonary disease (CTEPD) without resting pulmonary hypertension (PH) frequently experience dyspnea which is not explained by stationary assessment and therefore requires cardiopulmonary exercise testing for further diagnostic insight. Ventilatory inefficiency in CTEPD is commonly identified; however, consensus definitions are lacking. Upright iCPET and careful definition of ventilatory inefficiency (i.e., lack of reduction in VD/VT with exercise) may allow optimal characterization of patients with chronic thromboembolic disease and specifically helps correctly identify patients with preload insufficiency who may otherwise be misclassified or undiagnosed.
Red cell antibody and antigen patterns in patients with sickle cell disease: A multi‐center analysis
Covington, Mischa L. , Conrad, Stephanie , Evans, Mariama I., Fasano, Ross M., Forbes, Judith A, Johnson, Carolyn, Karafin, Matthew S. , Nakahara, Hirotomo , Poisson, Jessica , Sikora, James , Sofoluwe, Adeyemi Victor, Sullivan, Jensyn Cone , Thomasson, Reggie R. , Conrad, Stephanie , Karafin, Matthew , Campbell-Lee, Sally , Nakahara, Hirotomo , Poisson, Jessica L , Sikora, James , Cone Sullivan, Jensyn , Thomasson, Reggie R , Lu, Wen , Allen, Elizabeth S. , Chou, Stella T. , Fasano, Ross M. , Juskewitch, Justin E. , Stowell, Sean R. , Lu, Wen

Transfusion | April 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/trf.70213 | PMID 41968490 Get It

Abstract Background Red cell alloimmunization complicates sickle cell disease (SCD) management despite current widespread prophylactic Rh/K matching in the United States (US). Regional antibody patterns remain poorly characterized. Study Design and Methods We conducted a retrospective analysis of 2965 SCD patients from 9 US sites (2010–2022). All hospitals prophylactically match for Rh and K antigens. Each site collected demographics, antigen status, antibody histories, and antibody screen results from their laboratory information system. Results Overall antibody prevalence was 29.7% with dramatic institutional variation (17.9%–56.0%). Alloantibody prevalence was 27.5%. Most autoantibody‐positive patients (74.23%) also had alloantibodies, identifying a high‐risk population. A third of patients with positive antibody histories had negative screens. Pediatric patients showed markedly different antibody profiles than adults. Hospitals’ antibody patterns clustered by patient age rather than geography. Rh and K antibodies were the most common and also most likely to co‐occur, followed by S, Fya, and Jkb antibodies. Antibodies against Jsa (1.82%), V (1.75%), and Kpa (1.69%) were more prevalent than anti‐Jka (1.28%). Despite regional antibody variation, antigen frequencies remained overall consistent. In antigen–antibody pairwise comparisons, 3.15% were antigen‐negative and antibody‐positive reflecting alloimmunization; 0.47% were both antibody‐ and antigen‐positive, suggesting partial/variant antigens. Discussion Substantial institutional variation in antibody prevalence suggests need for site‐specific approaches to testing and prophylactic matching. High co‐occurrence of auto‐ and alloantibodies, antibody immunogenicity patterns, and antigen–antibody discordances support the need for further research and consideration of refined testing and/or matching strategies beyond the current Rh and K standard.
Bacterial Infections Role in Gynecological Cancers Development: Narrative Review
Azargun, Robab , Azargoon, Maryam , Asefy, Zahra , Yekani, Mina , Tarhriz, Vahideh , Yeganeh, Fatemeh , Memar, Mohammad Yousef , Eyvazi, Shirin , Eyvazi, Shirin

Cancer Reports | April 13, 2026 | Volume: 9 | Issue: 4 | Pages: No page available

10.1002/cnr2.70499 | PMID 41968380 Get It

ABSTRACT Background Gynecological cancers are among the most common cancers in women that affect female reproductive organs. The most common gynecological cancers are ovarian, cervical, uterine/endometrial, vaginal, and vulvar cancer. Women's reproductive organs have a dynamic and relative microbial balance. The disruption in the balance of the microbiome could result in numerous gynecological diseases, as well as, gynecological cancers. In this study, we aimed to review new findings on the role of different bacterial infections in various types of gynecological cancers. Recent Findings The role of bacterial infection, as an external factor, has been established in several cancers. However, the ways in which bacteria can promote the development of cancer are not fully understood. It seems that inflammation induced by bacterial infections could promote carcinogenesis. In addition, bacterial toxins and effector proteins play important roles in the progression of cancer. In this review, we attempt to present the different bacterial infections, which have been linked to gynecological cancers development. According to different researches, Chlamydia , Mycoplasma , and Bacteroides spp. are the most common bacterial infections associated with gynecological cancers. Conclusion Evaluation of microbiome in reproductive organs of the patients with gynecological cancer and studies on prevention and control of the infections in the patients could be useful in verification of pathogenesis of the diseases and also founding suitable therapeutic interventions.
Stopping Spin at the Source: Learning From an Example in Obesity
Brown, Andrew W. , Jensen, Michael D. , Allison, David B. , Jensen, Michael , Allison, David B

Obesity | April 12, 2026 | Volume: 34 | Issue: 6 | Pages: 1183-1186

10.1002/oby.70159 | PMID 41967833 Get It

Bronchial Mucosal Abnormalities in Idiopathic Subglottic Stenosis
Ring, Sydney , Bowen, Andrew J. , Griffin, Tessa C. , Ferguson, J. Scott , Dailey, Seth H. , Bowen, Andrew Jay , Griffin, Tessa

The Laryngoscope | April 12, 2026 | Volume: 136 | Issue: 8 | Pages: 3527-3533

10.1002/lary.70543 | PMID 41966683 Get It

ABSTRACT Objectives Investigate synchronous lower airway findings during bronchoscopy in idiopathic subglottic stenosis (iSGS). Methods Retrospective analysis of bronchoscopic images from adult iSGS patients (January 2018–June 2021). Images were reviewed for pits, depressions, nodules, and striations distal to the cricotracheal junction. Results Forty‐eight female patients; mean age 56 years. Comorbidities: gastroesophageal reflux 34%, hypertension 34%, diabetes mellitus 25%. All patients had pits and depressions; striations in 48/48, with both longitudinal and transverse in 32/48 (66.7%), transverse only in 13/48 (27.1%), and longitudinal only in 3/48 (6.3%). Spirometry available in 32; 60% showed normal or mild–moderate fixed obstruction. Four patients had FEV 1 /FVC < 0.7; two had asthma, one COPD, and one no obstructive diagnosis; none were smokers. Conclusion Bronchial mucosal abnormalities are prevalent in iSGS and may indicate distal airway involvement. Routine flexible bronchoscopy should be considered during evaluation and surveillance. Level of Evidence 4.
T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis
Joachimbauer, Anna , Perez-Shibayama, Christian Ivan, Payne, Emily, Hanka, Isabella, Stadler, Roman, Papadopoulou, Iliana , Rickli, Hans , Maeder, Micha T, Zdanytė, Monika , Cooper, Leslie, Matter, Christian M. , Wilzeck, Verena C, Manka, Robert, Saguner, Ardan M, Ruschitzka, Frank, Schmidt, Dörthe, Gil-Cruz, Cristina Del Carmen, Perez‐Shibayama, Christian , Stadler, Roman, Maeder, Micha T. , Borst, Oliver , Cooper, Leslie, Flatz, Lukas , Wilzeck, Verena , Manka, Robert , Saguner, Ardan M. , Ruschitzka, Frank T. , Ludewig, Burkhard , Gil‐Cruz, Cristina

No container title available | April 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.10.26350598 Get It

Abstract Background and Aims Acute myocarditis (AM) is a T cell-mediated myocardial disease with clinical manifestations ranging from mild chest pain to cardiogenic shock. Reliable biomarkers to stratify patients and guide therapy are currently lacking. In particular, the extent of the dysregulation of inflammatory pathways, and the impact on myocardial dysfunction, remain elusive. Methods Serum analyses were performed in prospectively recruited AM patients (n = 103) from two independent cohorts. Multimodal data integration combining profiling of cytokine and chemokine dysregulation with clinical biomarkers was used to define clinical phenotypes with distinct inflammatory signatures. Machine-learning and regression models were applied to determine biomarkers that indicate clinical severity. Results Immuno-proteomic profiling revealed conserved inflammatory patterns across AM cohorts, dominated by T cell-related cytokines and chemokines. In addition, AM patients showed dysregulation of fibroblast-derived cytokines, including hepatocyte growth factor (HGF), bone morphogenic protein 4 (BMP4) and the BMP4 inhibitors Gremlin-1 (GREM1) and Gremlin-2 (GREM2). Data integration and unsupervised clustering revealed two immuno-clinical phenotypes, linking T cell activation and fibroblast dysregulation to disease severity. Machine learning-based analysis identified CXCL10, GREM2 and LVEF as critical parameters for stratifying disease severity. Conclusions These findings highlight a systemic T cell activation signature as diagnostic hallmark of AM. In addition, dysregulation of fibroblast-derived tissue cytokines serves as an indicator for distinct immuno-clinical phenotypes in myocardial inflammatory disease. Thus, the clinically relevant link between T cell-driven immune activation, myocardial inflammation and fibroblast-driven remodelling provides a versatile set of parameters to identify severe manifestations of AM. Graphical Abstract Key Question: Are serological immune signatures linked to clinical severity in acute myocarditis and do they enable patient stratification? Key Findings: T cell- and fibroblast associated proteomic signatures indicate disease severity in acute myocarditis. Novel immuno-clinical phenotypes stratify patients according to distinct immune responses and clinical manifestations. CXCL10, GREM2 and LVEF are the most important parameters to identify immuno-clinical phenotypes. Take Home Message: CXCL10, GREM2 and LVEF emerge as key determinants for a severe immuno-clinical phenotype in acute myocarditis, highlighting the role of T cell-fibroblast interaction in the disease process and linking T cell activation, fibroblastic tissue remodelling and impaired cardiac function.